Peptides and peptide hormones for molecular imaging and disease diagnosis.
Peptides and peptide hormones for molecular imaging and disease diagnosis.
复制标题
DOI:
10.1021/cr900361p
复制
发表时间:
2010-05-12
期刊:
影响因子:
62.1
通讯作者:
Chen, Xiaoyuan
中科院分区:
文献类型:
--
作者:
Lee, Seulki;Xie, Jin;Chen, Xiaoyuan
Molecular imaging techniques are now indispensable tools in modern diagnostics, because they are highly specific and can provide biological information at the molecular level in living systems. 1, 2 They have enabled visualization of some of the specific molecular events that play key roles in disease processes, and they have enabled earlier diagnosis, as well as monitoring of therapeutic responses. Various imaging modalities, including positron emission tomography (PET), single photon emission computed tomography (SPECT), optical fluorescence imaging, magnetic resonance imaging (MRI), computed tomography, and ultrasound imaging, are all successfully employed in the field of molecular imaging. Specific imaging is generally created by contrast agents; however, most current clinical imaging remains at the anatomical and macrofunctional level, due to the low targeting efficiency of such agents. To support the unmet needs for in ViVo clinical molecular imaging, there has been considerable interest in investigating the design of highly sensitive and specific molecularly targeted imaging probes. To date, a large variety of sophisticated imaging probes have been developed by combining various imaging moieties (ie, radioisotopes, fluorophores, and nanoparticles) and targeting ligands (ie, small molecules, peptides, proteins, antibodies, as well as cells). These efforts have profoundly impacted the availability of imaging probes and significantly improved the performance of imaging modalities. Several review articles have discussed recent developments and applications of molecular imaging probes, 2–7 particularly the utilization of peptide-and peptide hormone-based imaging probes. An ideal imaging probe would have high affinity and specificity for the target of interest. However, requirements
登录
查看更多内容
DOI:
10.2967/jnumed.108.053546
发表时间:
2009-02
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
Budde MD;Frank JA
通讯作者:
Frank JA
DOI:
10.1073/pnas.152463399
发表时间:
2002-10-01
影响因子:
11.1
作者:
Åkerman, ME;Chan, WCW;Ruoslahti, E
通讯作者:
Ruoslahti, E
影响因子:
7.4
作者:
BRIGHT, FV
通讯作者:
BRIGHT, FV
影响因子:
46.9
作者:
Becker, A;Hessenius, C;Grötzinger, C
通讯作者:
Grötzinger, C
影响因子:
14.8
作者:
Blum, Galia;von Degenfeld, Georges;Bogyo, Matthew
通讯作者:
Bogyo, Matthew